Press releases | Finanzwire

PRESS RELEASE

published on 07/29/2024 at 18:00, 3 months 24 days ago

CORRECTING AND REPLACING: Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Annual mRNA-based Therapeutics Summit
Applied DNA Sciences presents Linea IVT platform as a solution for improved mRNA production at 4th Annual mRNA-based Therapeutics Summit. The platform reduces dsRNA contamination

Applied DNA Sciences Linea IVT Platform MRNA Production DsRNA Contamination Therapeutics Summit
PRESS RELEASE

published on 07/29/2024 at 17:57, 3 months 24 days ago

CORRECTING AND REPLACING: Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Annual mRNA-based Therapeutics Summit
Applied DNA Sciences, Inc. presents Linea IVT platform for enhanced mRNA production at 4th Annual mRNA-based Therapeutics Summit. Solution reduces dsRNA contamination, streamlines workflows, and boosts efficiency

Applied DNA Sciences MRNA Therapeutics Linea IVT Platform MRNA Production DsRNA Contamination
PRESS RELEASE

published on 07/29/2024 at 17:55, 3 months 24 days ago

2024 Half-Year Results Financial Report URW N.V.
REGULATED PRESS RELEASE

published on 07/29/2024 at 17:47, 3 months 24 days ago

Imerys-press-release-H1-2024-results-29-July-2024-VENG
PRESS RELEASE

published on 07/29/2024 at 17:45, 3 months 24 days ago

Periodic disclosure on the buyback program
Racing Force S.p.A. announces acquisition of 3,956 RFG shares on Euronext Growth Milan segment as part of treasury buy-back program. Company now holds 16,701 treasury shares

Racing Force S.p.A. Equita SIM S.p.A. Treasury Buy-back Program Euronext Growth Milan RFG Shares
REGULATED PRESS RELEASE

published on 07/29/2024 at 17:45, 3 months 24 days ago

Mersen: Record 2024 half-year sales of €624 million - 2024 guidance confirmed
Mersen reports record half-year sales of €624 million in 2024, with 4.9% organic growth. 2024 guidance confirmed. EBITDA margin up to 16.9%. Integration of GMI in the United States

Mersen EBITDA Margin 2024 Guidance Half-Year Sales GMI Integration
REGULATED PRESS RELEASE

published on 07/29/2024 at 17:45, 3 months 24 days ago

Disclosure of trading in own shares from July 22th, 2024, to July 26th, 2024. Detailed information per transaction
Lagardère SA discloses trading in own shares from July 22nd, 2024, to July 26th, 2024, through detailed transactions with BNP Paribas SA. Shares allocated to employees

Lagardère SA Trading Own Shares Employees BNP Paribas SA
REGULATED PRESS RELEASE

published on 07/29/2024 at 17:45, 3 months 24 days ago

Disclosure of trading in own shares from July 22th, 2024, to July 26th, 2024
Lagardère SA discloses trading in own shares from July 22nd to July 26th, 2024. Detailed information available on www.lagardere.com

Lagardère SA Investor Relations Trading Disclosure Own Shares
REGULATED PRESS RELEASE

published on 07/29/2024 at 17:35, 3 months 24 days ago

Disclosure of transactions in own shares on July 22 to July 26, 2024
PRESS RELEASE

published on 07/29/2024 at 17:15, 3 months 24 days ago

Coming Soon to Banff Sunshine Village This Winter 2024: The New Super Angel Luxury Chairlift
Banff Sunshine Village introduces North America's first EVO six-passenger, heated, luxury chairlift, Super Angel, enhancing guest experience with state-of-the-art technology and comfort

Banff Sunshine Village Guest Experience EVO Technology Super Angel Luxury Chairlift

Published on 11/22/2024 at 18:45, 43 minutes ago

CORRECTING and REPLACING the Not-So-Secret Lives of REAL "Mormon" Wives - the Eye-Opening New Book From Cedar Fort Publishing & Media - is Now Available for Purchase, Just in Time for Christmas
Published on 11/22/2024 at 16:00, 3 hours 28 minutes ago

Manimal Tales Unveils Two New Personalized Christmas-Themed Books to Spread Holiday Magic and Joy!
Published on 11/22/2024 at 15:55, 3 hours 33 minutes ago

Independent Proxy Advisory Firm ISS Recommends Signal Gold Shareholders Vote for Arrangement Resolution and Private Placement Resolution
Published on 11/22/2024 at 15:15, 4 hours 13 minutes ago

Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
Published on 11/22/2024 at 14:45, 4 hours 43 minutes ago

Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs

View all ACCESSWIRE

Published on 11/22/2024 at 18:14, 1 hour 14 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 18:00, 1 hour 28 minutes ago

Holding(s) in Company
Published on 11/22/2024 at 17:53, 1 hour 35 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 2 hours 33 minutes ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 3 hours 28 minutes ago

Proposed cancellation of admission to trading

View all EQS

Published on 11/22/2024 at 14:35, 4 hours 53 minutes ago

Thales Press release
Published on 11/21/2024 at 06:58, 1 day 12 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 1 hour ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 1 hour ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024

View all LES ECHOS COMFI WIRE

News